About the Customer
Ipsen is a French pharmaceutical company headquartered in Paris, France. It primarily develops and markets medications used in oncology, endocrinology and the treatment of neuromuscular disorders. It is publicly traded on the Euronext Paris
Scope and Challenges
The company started looking for a solution in 2018 to manage the company’s global supply chain in support of the company’s SPEED initiative to achieve high business growth.
In mid of 2018, Ipsen selected Kinaxis's SCM application Kinaxis RapidResponse.
Outcome and Implications
The implementation of the product is expected to go live in 2019.
Meanwhile, the decision makers of the company are expecting that deploying Kinaxis will solve the challenges they had and will help them to manage worldwide inventory and gain complete visibility and control over the company’s product supply and demand.
Kinaxis will help Ipsen reduce effective lead times to customer delivery by leveraging the product’s collaborative planning capability, helping eliminate stock shortages while shortening new product approval timelines making new medicines available to patients that much more quickly.
“With RapidResponse and it's powerful concurrent planning capabilities we will be able to account for every element impacting supply and demand in our global operation. The ability to run ‘what-if’ scenarios with RapidResponse will help us better understand our supply chain and more accurately forecast changes in demand and related impacts on operations, end-to-end. Our decisions will be more informed, which will benefit both our business and, more importantly, those who rely on our vital products.” - said Ronan Stephens, Senior Vice President, Global Supply Chain and External Manufacturing, Ipsen.
|Category||SubCategory||Vendor||Old Product||New Product||Function||Market||Users||VAR/SI||When||Live|
|First Name||Last Name||Title||Company||Phone|